Concept paper on new guidance on the clinical investigation of medicinal products for the treatment of idiopathic pulmonary fibrosis (IPF)
Concept paper on new guidance on the clinical investigation of medicinal products for the treatment of idiopathic pulmonary fibrosis (IPF)
Concept paper on a paediatric update of the guideline on clinical investigation of medicinal products for the management of Crohn’s disease
Concept paper on a paediatric update of the guideline on clinical investigation of medicinal products for the management of Crohn’s disease
Concept paper on a paediatric update on the guideline on the development of new medicinal products for the treatment of Ulcerative Colitis
Concept paper on a paediatric update on the guideline on the development of new medicinal products for the treatment of Ulcerative Colitis
EMEA-003156-PIP02-22
EMEA-003156-PIP02-22
Records of data processing activity for internal publication of appointments, transfers and departures
Records of data processing activity for internal publication of appointments, transfers and departures
Human medicines European public assessment report (EPAR): Sitagliptin / Metformin hydrochloride Accord, sitagliptin,metformin hydrochloride, Date of authorisation: 22/07/2022, Revision: 3, Status: Lapsed
Human medicines European public assessment report (EPAR): Sitagliptin / Metformin hydrochloride Accord, sitagliptin,metformin hydrochloride, Date of authorisation: 22/07/2022, Revision: 3, Status: Lapsed
Human medicines European public assessment report (EPAR): Efient, prasugrel, Date of authorisation: 24/02/2009, Revision: 28, Status: Authorised
Human medicines European public assessment report (EPAR): Efient, prasugrel, Date of authorisation: 24/02/2009, Revision: 28, Status: Authorised
European medicines regulatory network incident management plan for medicines for human use
European medicines regulatory network incident management plan for medicines for human use
Draft guideline on non-inferiority and equivalence comparisons in clinical trials
Draft guideline on non-inferiority and equivalence comparisons in clinical trials
